Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05770882
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-02-07
Brief Title:
Chidamide Regorafenib in Hepatocellular Carcinoma HCC
Sponsor:
Great Novel Therapeutics Biotech Medicals Corporation
Organization:
Great Novel Therapeutics Biotech Medicals Corporation
Organization Data
Organization:
Great Novel Therapeutics Biotech Medicals Corporation
Class:
INDUSTRY
Study ID:
KEPIDA-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Great Novel Therapeutics Biotech Medicals Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None